156 related articles for article (PubMed ID: 38297280)
1. ZNF148 inhibits HBV replication by downregulating RXRα transcription.
Yao X; Xu K; Tao N; Cheng S; Chen H; Zhang D; Yang M; Tan M; Yu H; Chen P; Zhan Z; He S; Li R; Wang C; Wu D; Ren J
Virol J; 2024 Jan; 21(1):35. PubMed ID: 38297280
[TBL] [Abstract][Full Text] [Related]
2. Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.
Song M; Sun Y; Tian J; He W; Xu G; Jing Z; Li W
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437960
[TBL] [Abstract][Full Text] [Related]
3. Retinoid X Receptor α-Dependent HBV Minichromosome Remodeling and Viral Replication.
Zhang Y; He S; Guo JJ; Peng H; Fan JH; Li QL
Ann Hepatol; 2017; 16(4):501-509. PubMed ID: 28611266
[TBL] [Abstract][Full Text] [Related]
4. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
[TBL] [Abstract][Full Text] [Related]
6. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.
Shen Z; Zhang S; Gao Z; Yu X; Wang J; Pan S; Kang N; Liu N; Xu H; Liu M; Yang Y; Deng Q; Liu J; Xie Y; Zhang J
J Virol; 2024 Feb; 98(2):e0134523. PubMed ID: 38226815
[TBL] [Abstract][Full Text] [Related]
8. SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity.
Yang H; Zhou Y; Mo J; Xiang Q; Qin M; Liu W; Shang J; Yang Q; Xu W; Yang G; Tan Q; Wu K; Liu Y; Wu J
Antiviral Res; 2020 May; 177():104761. PubMed ID: 32147495
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
[TBL] [Abstract][Full Text] [Related]
10. HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver.
Yuan H; Zhao L; Yuan Y; Yun H; Zheng W; Geng Y; Yang G; Wang Y; Zhao M; Zhang X
Theranostics; 2021; 11(17):8362-8378. PubMed ID: 34373747
[No Abstract] [Full Text] [Related]
11. [Zinc finger E-box-binding homeobox 2 inhibits hepatitis B virus replication and expression].
Li XP; Hu Q; He Q; Chen WX
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):824-828. PubMed ID: 27978927
[No Abstract] [Full Text] [Related]
12. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
13. Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription.
Ren F; Zhao S; He X; Lo H; Wong VKW; Law BYK; Wu A; Zhang J
J Med Virol; 2024 May; 96(5):e29669. PubMed ID: 38773784
[TBL] [Abstract][Full Text] [Related]
14. Designed Artificial Transcription Factors Inhibit Hepatitis B Virus Transcription in HepG2.2.15 Cells.
Fu Y; Chen C; Zhang Y; Li Z; Wei X; Tan X
Ann Clin Lab Sci; 2020 Jan; 50(1):92-98. PubMed ID: 32161017
[TBL] [Abstract][Full Text] [Related]
15. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
[No Abstract] [Full Text] [Related]
16. A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection.
Zhang K; Lai X; Song J; He L; Wang L; Ou G; Tian X; Wang L; Deng J; Zhang J; Li C; Zhuang H; Li T; Xiang K
Antiviral Res; 2021 May; 189():105061. PubMed ID: 33705864
[TBL] [Abstract][Full Text] [Related]
17. Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway.
Wen X; Li D; Chen P; Tan M; Zhang H; Liu Y; Ren J; Cheng S
Virus Res; 2024 Jan; 339():199273. PubMed ID: 38029800
[TBL] [Abstract][Full Text] [Related]
18. NTCP-Reconstituted In Vitro HBV Infection System.
Sun Y; Qi Y; Peng B; Li W
Methods Mol Biol; 2017; 1540():1-14. PubMed ID: 27975303
[TBL] [Abstract][Full Text] [Related]
19. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
